Navigation Links
World's Oldest High-wire Artiste Hums Along at 98

Kassel (Germany): Konrad Thurano, 98, is not too good on his legs, even with the aid of a walking stick, but put him on a tightrope and he seems// years - no, decades - younger.

Thurano believes he is the world's oldest high-wire artiste still performing, and no one has found an active centenarian acrobat to disprove this, so it's probably true. At a birthday party this week in the German city of Kassel, he did a few pull-ups to a wire to demonstrate.

'I feel as fit as ever,' he said. Not very loudly, but the words were clear. 'My eyes and ears haven't done too well, but my arms and legs are still doing what they are supposed to do.'

Shuffling over to the wire stretched between two walls, he pulls himself up, by his wrists at first, then by his hands and finally by just his index fingers.

His eyes twinkle from under his black-brimmed hat.

He has performed in a variety theatres for more than 80 years and has known many of the greatest singers and other international performers who filled the variety houses of the 20th century.

Jerry Lewis, Marlene Dietrich, Sammy Davis jr. Dean Martin and Frank Sinatra all knew Thurano. He once even met Charlie Chaplin.

'Those were great days,' says Thurano's son Johnjohn. 'The top artistes used to spend time together on ocean liners or on first-class trains. There was camaraderie among them.'

'I'm not giving up now,' declares Thurano with a cheeky schoolboy grin. 'Keep happy, I say. Maybe I'll make 100.'

Asked about the secret of his old age, he reckons he did nothing special.

'I ate what anyone eats: lots of fruit, but I like meat and pasta too. I even used to smoke, until I was 50.

'I don't do any special exercises either. Oh, you know, I just run a few km every day on my treadmill at home.'

In January 2006, Thurano had a farewell variety performance, his family says, but he puts up his
'"/>




Page: 1 2

Related medicine news :

1. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
2. Worlds oldest turns 116 in Japan
3. Indian Doctor in Worlds 65 caring doctors
4. Worlds Smallest Fish Found In Indonesia
5. Worlds First Cervical Cancer Vaccine to go on Sale
6. Italian Doctors To Operate On Worlds Fattest Man
7. Worlds 3 out of 10 Cigarettes Smoked in China
8. Diabetes Labeled As Worlds Fifth Killer Disease
9. Scientists Trace the Roots of the Worlds Healthiest Wines
10. Worlds Oldest Mother Admits Her Actual Age
11. The Worlds First Digital Insulin Pen With a Memory Launched
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: World Oldest High wire Artiste Hums Along

(Date:12/5/2009)Midbrook,s advanced Technology Center helps companies develop and test their cleaning processes. The technology available to the lab allows it to work in a variety of industries and solve problems for
(Date:12/4/2009)NEW YORK, Dec. 4 Care Investment Trust Inc. (NYSE: CRE ) ("Care" or the "Company") today announced that its Board of Directors has declared a dividend of $0.17 per share of common stock. The div
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
Breaking Medicine News(10 mins):Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Human guinea pigs wary of high-paying medical trials 2
... cases at the Brisbane studios of Australian Broad...ern among its staff. Former news assistant...e among the ABC staff who worked at the now-abando...f compensation for those diagnosed with the diseas...
...e into claims that Paris Hilton received preferent...cility last month. Rumours were rife that t...of probation, was given several privileges by the ...rm instead of a recycled one given to other inmate...
... at a pal's home after her break-up with troubled ...ermodel is staying with celebrity hairdresser and ... Babyshambles frontman's infidelity. Moss ...rned a collection of love letters and poetry which...
...s Center have revealed that genes play a large rol...aste perception. The findings may help re...r that detects sourness in foods and beverages, ju...ds in foods and beverages. In fact, the word acid ...
...ly approved a plan to give families 2,500 euros (3...flagging birth rate . First Deputy Prime M...lowing Friday's cabinet meeting the measure would ...amilies who have had children, including adopted i...
...as urged its six million "sexually active" citizen...ational campaign starts Monday . Health au...tatistics had shown that out of "six million sexua...ow that they are carrying the virus because they h...
Other Medicine News:Health News:More Cancer Testing Urged in Australian TV Studios 2Health News:More Cancer Testing Urged in Australian TV Studios 3Health News:Genes Play Major Role in Determining Individual's Sour Taste Perception 2
(Date:12/3/2009)DOYLESTOWN, Pa., Dec. 3 Ted Karkus, Chairman and CEO of The Quigley Corporation, (Nasdaq: QGLY ) www.quigleyco.com announced today that the Company has completed its evaluation of its opportunitie
(Date:12/3/2009)WARRENDALE, Pa., Dec. 3 Radiology imaging leader MEDRAD, Inc. demonstrated PACS* injection-record integration capabilities at the November 2009 Radiology Society of North America in Chicago. The Co
(Date:12/3/2009)HOERSHOLM, Denmark and SAN DIEGO, California, December 3 , - SPC3649 Successfully Inhibits miR-122, a microRNA Important for,Hepatitis C Viral Replication, Thereby Significantly Reducing Hepatiti
Breaking Medicine Technology:Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5California Cancer Specialists Medical Group Inc finds clinical benefit in RapidArc 28TM 29 technology and executes strategic vendor agreement with V 58392 1California Cancer Specialists Medical Group Inc finds clinical benefit in RapidArc 28TM 29 technology and executes strategic vendor agreement with V 58392 2Illinois based AthletiCo Opens 53rd Physical Therapy Center in Elk Grove Village 58387 1Illinois based AthletiCo Opens 53rd Physical Therapy Center in Elk Grove Village 58387 2Illinois based AthletiCo Opens 53rd Physical Therapy Center in Elk Grove Village 58387 3Winnick Family Scholarship Awarded to Ramona Davoudpour at UCLA School of Medicine 58383 1Winnick Family Scholarship Awarded to Ramona Davoudpour at UCLA School of Medicine 58383 2Winnick Family Scholarship Awarded to Ramona Davoudpour at UCLA School of Medicine 58383 3Winnick Family Scholarship Awarded to Ramona Davoudpour at UCLA School of Medicine 58383 4
...ngs Published in Blood Highlight Millennium Leader... the Role of VELCADE as,Foundation of Therapy in B...GE, Mass., April 17, 2007 /PRNewswire-FirstCall/ -...ood show that a,team of researchers led by Millenn...s which may lead to identifying multiple,myeloma p...
...nation Therapy Significantly Decreased Tumor Blood...umors -, LOS ANGELES and TUSTIN, Calif., April 17,...uticals, Inc. , a,clinical stage biopharmaceutical... for the treatment of cancer and hepatitis C,virus... data,presented at the Centennial Annual Meeting o...
Other Medicine Technology:Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 2Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 3Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 4Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 5Millennium Discovers Biomarkers Potentially Predictive of Response,to Velcade (Bortezomib) for Injection 6Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 2Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 3Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 4Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus,Docetaxel Reduces Growth of Both Hormone-Dependent and,Hormone-Independent Prostate Cancer by Up to 94 Percent in,Preclinical Studies 5
Finnpipette Fixed Volume, 20ul
Pipetman F1000
Finnpipette Focus Fixed Volume, 1ul
Finnpipette Fixed Volume, 2ul
Medicine Products: